Wyss Center Neurotech Challenge: Can You Connect the Human Brain with Digital World?

The Wyss Center, a not-for-profit neurotechnology organization based in Geneva, Switzerland, has launched a global neurotech innovation challenge to connect the human brain with the digital world. The Challenge seeks the most disruptive new technologies for brain stimulation and neural signal recording. The goal is to develop technology with a clinical application that could help paralyzed people move, overcome depression or memory loss, restore vision or address other nervous system disorders.

Open to anyone, from anywhere in the world, the award will provide access to the expertise and technical facilities at the Wyss Center as well as funding to translate the successful idea from research concept into a clinical application.

Accommodation and salary for the project leader in the beautiful Lake Geneva region of Switzerland will be included in the award for a minimum of a year in addition to ongoing funding for the project.

The deadline for entries to the Wyss Center Neurotech Challenge is the 1st February 2017.

Proposals may be sent out for independent external review. A short list will be announced on February 14 and the winner will be announced in April 2017.

For further information, please visit:
http://www.wysscenter.ch/en/neurotech-challenge

About the Wyss Center for Bio and Neuroengineering
The Wyss Center provides the expertise, facilities and resources to accelerate the development of creative neuroscience research into clinical solutions for human benefit.

Based at Campus Biotech in Geneva Switzerland, the Wyss Center offers competitively awarded project funding for innovative neurotechnology research projects that have the potential to make substantial impact.

The Center provides access to advanced neuroscience and engineering facilities, as well as the integrated clinical, regulatory and business resources required to guide high risk, high return projects on their the complex journey from research to product.

The Wyss Center's unique interdisciplinary team of specialists, including research scientists, engineers, regulatory experts, business development specialists and clinicians, help to develop the products that will prevent, diagnose or treat nervous system disorders, or will lead to useful technology with the potential to improve lives.

The Center will support highly innovative neurotechnology projects from anywhere in the world as long as they fit the core mission to accelerate the development of neurotechnology for human benefit and make full use of the Center's capabilities and resources.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...